1. Home
  2. QCOM vs SNY Comparison

QCOM vs SNY Comparison

Compare QCOM & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QUALCOMM Incorporated

QCOM

QUALCOMM Incorporated

N/A

Current Price

$146.35

Market Cap

145.4B

Sector

Technology

ML Signal

N/A

Logo Sanofi ADS

SNY

Sanofi ADS

N/A

Current Price

$47.50

Market Cap

119.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QCOM
SNY
Founded
1985
1994
Country
United States
France
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
145.4B
119.4B
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
QCOM
SNY
Price
$146.35
$47.50
Analyst Decision
Buy
Buy
Analyst Count
20
6
Target Price
$170.89
$61.50
AVG Volume (30 Days)
10.0M
4.4M
Earning Date
05-06-2026
01-01-0001
Dividend Yield
2.44%
3.36%
EPS Growth
N/A
N/A
EPS
2.78
N/A
Revenue
$44,284,000,000.00
N/A
Revenue This Year
$0.90
$2.62
Revenue Next Year
$0.77
$6.38
P/E Ratio
$52.48
$6.14
Revenue Growth
13.66
N/A
52 Week Low
$120.80
$44.62
52 Week High
$205.55
$60.12

Technical Indicators

Market Signals
Indicator
QCOM
SNY
Relative Strength Index (RSI) 46.81 50.58
Support Level $142.94 $47.30
Resistance Level $149.30 $49.28
Average True Range (ATR) 3.49 0.72
MACD 1.54 0.05
Stochastic Oscillator 96.26 45.53

Price Performance

Historical Comparison
QCOM
SNY

About QCOM QUALCOMM Incorporated

Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G, 4G, and 5G networks. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones, as well as chips into automotive and Internet of Things markets.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: